What sector does Santen Pharmaceutical Co Ltd (4536) operate in?
Santen Pharmaceutical Co Ltd belongs to the Healthcare sector and operates in the Drug Manufacturers - General industry.
What is Santen Pharmaceutical Co Ltd (4536) current stock price?
As of the latest data, Santen Pharmaceutical Co Ltd stock price is ¥1,659, with a previous close of ¥1,662. Santen Pharmaceutical Co Ltd lost -¥3 in the last trading session, representing a -0.15% loss.
What is Santen Pharmaceutical Co Ltd (4536) current market capitalization?
Santen Pharmaceutical Co Ltd market cap is approximately 564.75 billion.
What is Santen Pharmaceutical Co Ltd (4536) Earnings Per Share (EPS)?
The trailing EPS is ¥104.
What is Santen Pharmaceutical Co Ltd (4536) Price-to-Earnings (P/E) ratio?
Santen Pharmaceutical Co Ltd current P/E ratio is 15.99.
What is Santen Pharmaceutical Co Ltd (4536) EBITDA?
Santen Pharmaceutical Co Ltd EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 18.66 billion.
Does Santen Pharmaceutical Co Ltd (4536) pay dividends?
Yes. Santen Pharmaceutical Co Ltd pays semiannual dividends with an annualized yield of 2.29% and an estimated annual payout of ¥38 per share.
When is the next ex-dividend date for Santen Pharmaceutical Co Ltd (4536)?
The next ex-dividend date is scheduled for September 28, 2025.
How did Santen Pharmaceutical Co Ltd (4536) perform in its most recent earnings report?
In the last report (March 31, 2025), Santen Pharmaceutical Co Ltd posted an EPS surprise of 61.09% and a revenue surprise of -74.18%.
When is Santen Pharmaceutical Co Ltd (4536) next earnings report?
Santen Pharmaceutical Co Ltd is expected to release its next earnings report on June 30, 2025.
What is Santen Pharmaceutical Co Ltd (4536) beta (volatility) score?
Santen Pharmaceutical Co Ltd has a beta of 0.215, indicating lower volatility than the overall market.